Zdrowie i gospodarka · 23/06/2017

FDA to Host Public Meeting on Patient-Focused Drug Development for Alopecia Areata, Seeks Public Comments

The FDA is hosting a public meeting to gather patients' perspectives on alopecia areata and treatment approaches, as part of its Patient-Focused Drug Development initiative under the Prescription Drug User Fee Act (PDUFA V)